Efficacy and Safety of BI 425809 Once Daily in Patients With Schizophrenia: Top-Line Phase II Results
NEUROPSYCHOPHARMACOLOGY(2020)
Key words
Schizophrenia,BI 425809,Cognitive Impairment
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined